Login
$KRRO
$12.71 -$0.90 (6.61%) Live

Company Executives

Officer In this role 2025 pay Source
Ram Aiyar Also a director
President and CEO
Title from the Form 4 dated Aug 4, 2026
Not stated $3,119,591
Todd Chappell
Chief Operating Officer
Since 2023
3 years
Not reported
Jeffrey Cerio
Senior Vice President, General Counsel and Corporate Secretary
Since 2024
2 years
$1,578,451
Loïc Vincent
Chief Scientific Officer
Since 2025
1 year
$1,573,067
Loic A Vincent
Chief Scientific Officer
Title from the Form 4 dated Jul 15, 2026
Not stated Not reported
Oliver Dolan
Senior Vice President, Finance
Title from the Form 4 dated Sep 11, 2026
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
0 of 1
stated in the proxy; 6 not stated
Average tenure
2.9 years
from year joined
CEO also chairs the board
No
Nessan Bermingham
Director On board Independent Committees Other public boards 2025 pay Source
Nessan Bermingham
2023
3 years
Not stated
audit compensation · Chair
None stated $148,760
Ram Aiyar
2023
3 years
Not independent None stated None stated Paid as CEO
Rachel Meyers
2023
3 years
Not stated
nominating and corporate governance
None stated $105,260
Ali Behbahani
2023
3 years
Not stated
compensation nominating and corporate governance · Chair
Monte Rosa Therapeutics, Inc. $114,260
Jean-François Formela
2023
3 years
Not stated
audit nominating and corporate governance
None stated $112,760
Katharine Knobil
2024
2 years
Not stated
compensation
Marker Therapeutics, Inc. $106,260
Timothy Pearson
2023
3 years
Not stated
audit · Chair compensation
None stated $121,260

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 16, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support